Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: Description of successful outcomes

Australian Journal of Rural Health

Volumn 12, Issue 5, 2004, Pages 197-200

  Jackson, Shane L ^a   Peterson, Gregory M ^a   House, Murray ^b   Bartlett, Timothy ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b Wells and Wragg Pharmacy   (Australia)

^c Bartletts Capital Chemist   (Australia)

Author keywords

INR; Near patient testing; Pharmacy; Point of care; Rural; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; BIMATOPROST; CANDESARTAN; DIGOXIN; PANTOPRAZOLE; SIMVASTATIN; WARFARIN;

ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTHRITIS; ARTICLE; AUSTRALIA; CASE REPORT; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG MONITORING; DYSPEPSIA; FEMALE; GLAUCOMA; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MALE; MONITOR; NONBIOLOGICAL MODEL; PATIENT CARE; PATIENT COMPLIANCE; PHARMACIST; PRIORITY JOURNAL; RURAL HEALTH CARE; RURAL POPULATION; STROKE; THROMBOSIS; TREATMENT OUTCOME;

ANTICOAGULANTS; AUSTRALIA; DRUG MONITORING; FAMILY PRACTICE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICALLY UNDERSERVED AREA; MODELS, ORGANIZATIONAL; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PHARMACIES; POINT-OF-CARE SYSTEMS; PROFESSIONAL ROLE; RURAL HEALTH SERVICES; WARFARIN;

EID: 11844255381     PISSN: 10385282     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1854.2004.00604.x     Document Type: Article

References (25)

1. Rigby K, Clark R, Runciman W. Adverse events in health care: Setting priorities based on economic evaluation. Journal of Quality in Clinical Practice 1999; 19: 7-12.
2. Gallus A. Towards the safer use of warfarin I. An overview. Journal of Quality in Clinical Practice 1999; 19: 55-59.
3. Tripodi A, Chantarangkul V, Mannucci PM. Near-patient testing devices to monitor oral anticoagulant therapy [Review]. British Journal of Haematology 2001; 113: 847-852.
4. Hart RG, Palacio S, Pearce LA. Atrial fibrillation, stroke, and acute antithrombotic therapy: Analysis of randomized clinical trials. Stroke 2002; 33: 2722-2727.
5. Gage BF, Boechler M, Doggette AL et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke 2000; 31 822-827.
6. Flaker GC, McGowan DJ, Boechler M, Fortune G, Gage B. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. American Heart Journal 1999; 137: 307-312.
7. Healthy Horizons. A Framework for Improving the Health of Rural, Regional and Remote Australians. A Joint Development of the National Rural Health Policy Forum and the National Rural Health Alliance. For the Australian Health Ministers' Conference 1999. (Available from http://www7.health.gov.au/hsdd/horizons/; Accessed on 1 November 2004).
8. Australian Institute of Health and Welfare. Australia's Health 2002. AIHW Cat. no. AUS. 25. Canberra: AIHW, 2002.
9. Australian Institute of Health and Welfare. Health in Rural and Remote Australia. AIHW Cat. no. PHE. 6. Canberra: AIHW, 1998.
10. Human Rights and Equal Opportunity Commission. The State of Rural Health. Rural and remote health in Australia. Healthy Community Projects. Sydney: Human Rights and Equal Opportunity Commission, 2001. Available from www.hreoc.gov.au/human_rights/rural_health/state_of_rural_health.html.
11. McElduff P, Dobson AJ. Trends in coronary heart disease: has the socio-economic differential changed? Australia and New Zealand Journal of Public Health 2000; 24: 465-473.
12. Bennett S. Cardiovascular risk factors in Australia: trends in socioeconomic inequalities. Journal of Epidemiological Communications Health 1995; 49: 363-372.
13. Bennett S. Socioeconomic inequalities in coronary heart disease and stroke mortality among Australian men, 1979-93. International Journal of Epidemiology 1996; 25: 266-275.
14. Taylor R, Chey T, Bauman A, Webster I. Socio-economic, migrant and geographic differentials in coronary heart disease occurrence in New South Wales. Australia and New Zealand Journal of Public Health 1999; 23: 20-26.
15. Sexton PT, Sexon TLH. Excess coronary mortality among Australian men and women living outside the capital city statistical divisions. Medical Journal of Australia 2000; 172: 370-374.
16. Heller RF. Mortality from cardiovascular disease is too high outside capital cities. Medical Journal of Australia 2000; 172 360-361.
17. Oldenburg B, McGuffog ID, Turrell G. Socioeconomic determinants of health in Australia: policy responses and intervention options. Medical Journal of Australia 2000; 172: 489-492.
18. Peterson GM, Boom K, Jackson SL, Vial JH. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention. Internal Medicine Journal 2002; 32: 15-23.
19. Price CP. Regular review: Point of care testing [Review]. British Medical Journal 2001; 322: 1285-1288.
20. Thulin LI. International travel amongst patients on chronic anticoagulation therapy. Cor et Vasa 1988; 30: 292-297.
21. Pubentz MJ, Calcagno DE, Jr., Teeters JL. Improving warfarin anticoagulation therapy in a community health system. Pharmacy Practice Management Quarterly 1998; 18: 1-16.
22. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. American Journal of Hospital Pharmacy 1992; 49: 387-394.
23. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: A case-control study. American Journal of Medicine 1997; 103: 11-17.
24. Jackson SL, Bereznicki LR, Peterson GM et al. Accuracy, reproducibility and Clinical utility of the CoaguCheck S portable international normalized ratio monitor in all outpatient anticoagilation clinic. Clinical and Laboratory Haematology 2004; 26: 49-55.
25. Murray ET, Fitzmaurice DA, Allan TF, Hobbs FD. A primary care evaluation of three near patient coagulometers. Journal of Clinical Pathology 1999; 52: 842-845.